Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis

مزيد من المنشورات

Increased Permeability of the Blood–Brain Barrier in a Diabetic Mouse Model (Leprdb/db Mice)

بواسطة Musaad A. Alshammari , Abdulaziz O. Alshehri, Faleh Alqahtani , Mohammad R. Khan, Muhammed A. Bakhrebah , Fawaz Alasmari , Tahani K. Alshammari and Shakir D. Alsharari

2024

تم النشر فى:

International Journal of Molecular Science

Cathepsin-B inhibitor CA-074 attenuates retinopathy and optic neuritis in experimental autoimmune encephalomyelitis induced in SJL/J mice

بواسطة Mohammad Rashid Khan, Sheikh Fayaz Ahmad, Ahmed Nadeem, Faisal Imam, Naif O. Al-Harbi, Mohd Shahnawaz Khan, Meshal Alsahli, Khaled Alhosaini

2023

تم النشر فى:

Saudi Pharmaceutical Journal

Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis

بواسطة Mushtaq A. Ansari, Ahmed Nadeem, Musaad A. Alshammari, Sabry M. Attia, Saleh A. Bakheet, Mohammad R. Khan, Thamer H. Albekairi, Abdullah F. Alasmari, Khaled Alhosaini, Faleh Alqahtani, Haneen A. Al-Mazroua, Sheikh F. Ahmad

2022